Searched for
AMEERA SUSHIL SHAH
I-Sec upgrades Metropolis Healthcare to Buy, lowers target price to Rs 2,250ICICI Securities has upgraded Metropolis Healthcare to Buy, setting a target price of Rs 2,250. The company reported a net profit of Rs 31....
Add Metropolis Healthcare, target price Rs 2,335: ICICI SecuritiesICICI Securities maintains an Add rating on Metropolis Healthcare with a raised target price of Rs 2,335. Metropolis is acquiring Core Diag...
Buy Metropolis Healthcare, target price Rs 1420: Sharekhan by BNP ParibasMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6849.87 Crore) operating in Hospitals...
Buy Metropolis Healthcare, target price Rs 1775: JM FinancialMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6731.32 Crore) operating in Hospitals...
Buy Metropolis Healthcare, target price Rs 1978: BNP Paribas SecuritiesPromoters held 49.79 per cent stake in the company as of 30-Jun-2022, while FIIs owned 23.2 per cent, DIIs 14.5 per cent.
Ameera Sushil Shah, Managing Director of Metropolis Lab buys Sunder Nagar bungalow for Rs 64 croreAccording to documents accessed by CRE Matrix, a real estate data analytics firm, Star hotel PVR Ltd has sold the bungalow and property has...
GSK Velu in talks with investors, PEs & banking firms to buy Metropolis Healthcare stakeMetropolis chief executive Ameera Shah and her family has initiated a formal process to sell part of the promoter stake and is understood t...
Amazon, Walmart's Flipkart in talks to buy stake in $1.1 billion diagnostics chain Metropolis HealthcareThe company is in early discussions with several global strategic investors and other potential purchasers of the shares, said the people, ...
Harsh Mariwala wins EY Entrepreneur of the year 2020 awardSuresh Narayanan, chairman and managing director, Nestle India won the Entrepreneurial CEO award and Byju Raveendran, founder and chief exe...
Being a woman entrepreneur can be lonely, important to have mentors: Ameera ShahThe Metropolis Healthcare MD says that it's important to talk about mistakes as well.
Metropolis IPO gets oversubscribed 5.8xThe quota for qualified institutional buyers (QIBs) was over subscribed 8.8 times.
Metropolis eyes SRL in spinoff dealMetropolis was exploring a consolidation deal which could make it the largest diagnostics chain in Asia’s third-largest economy, sources sa...
Entrepreneur Velu back in diagnosticsThe re-entry puts him in direct competition with his former partner, Ameera Shah.
An equal music: How Ashni Biyani & Lara Balsara overcame gender bias in the boardroomThe boardroom can be a tough place for women, even for those with famous dads.
Meet India’s next generation of women leaders in pharmaThey are not afraid of taking business risks or foraying into newer businesses and have created environment and pushed for HR reforms targe...
Carlyle to buy 37% stake in diagnostics chain MetropolisGlobal private equity fund Carlyle is buying 37% stake in diagnostics chain Metropolis from one of its founders GSK Velu.
Carlyle may end Metropolis feud with Rs 900 crore stake buyMetropolis s today a multinational chain with more than 125 laboratories, tracking Rs 600-crore revenue annually.
Metropolis boardroom becomes a battleground: Warburg Pincus’ stake sale to Shahs irks partner VeluDr GSK Velu has reacted angrily to last week’s transaction between Warburg and the Shah family, which resulted in the Shahs increasing thei...
Top PEs including Apax Partners & Temasek eye a deal in Metropolis HealthcareThe dealmaking in Metropolis coincides with IPO plans of other players, notably Dr Lal Pathlabs, SRL and Thyrocare, all of whom could list ...